Ocaperidone 2 mg | 99.94%
TargetMol
Ocaperidona (Ocaperidone), a very high affinity dopamine D2 antagonist.
More Information Supplier PageOcaperidone
Search Results
Piribedil 25 mg | Purity Not Available
TargetMol
Piribedil is a dopamine D2 agonist, used in the treatment of Parkinson’s disease.
More Information Supplier PagePiribedil
Dihydralazine sulfate 200 mg | Purity Not Available
TargetMol
Dihydralazine sulfate
Dihydralazine sulfate 25 mg | Purity Not Available
TargetMol
Dihydralazine sulfate
Lumefantrine 200 mg | 100.00%
TargetMol
Lumefantrine is an antimalarial agent used to treat acute uncomplicated malaria. It is administered in combination with artemether for improved efficacy. This combination therapy exerts its effects against the erythrocytic stages of Plasmodium spp. and may be used to treat infections caused by P. falciparum and unidentified Plasmodium species, including infections acquired in chloroquine-resistant areas.
More Information Supplier PageLumefantrine
Stachydrine Hydrochloride 100 mg | 98.45%
TargetMol
Stachydrine Hydrochloride is an effective component that mainly extracted from the leaf of Leonurussibiricus.
More Information Supplier PageStachydrine Hydrochloride
Rebaudioside A 200 mg | 99.94%
TargetMol
Rebaudioside A is a novel agent of glycoside clathration of pharmacons, acts as α-glucosidase inhibitor.
More Information Supplier PageRebaudioside A
Piribedil 200 mg | Purity Not Available
TargetMol
Piribedil is a dopamine D2 agonist, used in the treatment of Parkinson’s disease.
More Information Supplier PagePiribedil
Dizocilpine Maleate 100 mg | 99.96%
TargetMol
Dizocilpine Maleate (MK 801) is a potent noncompetitive antagonist of the NMDA receptor (RECEPTORS, N-METHYL-D-ASPARTATE) with Kd of 37.2 nM in rat brain membranes. The drug has been considered for the wide variety of neurodegenerative conditions or disorders in which NMDA receptors may play an important role.
More Information Supplier PageDizocilpine Maleate
ITSA-1 200 mg | 99.82%
TargetMol
ITSA-1 is membrane permeable and specifically suppresses TSA inhibition of HDAC (histone deacetylase), but shows no activity towards other HDAC inhibitors.
More Information Supplier PageITSA-1
